Archives
-
Pam3CSK4 TFA for TLR1/2 Cytokine Studies
2026-09-30
Pam3CSK4 TFA provides a defined, synthetic route to TLR1/2 stimulation for cytokine profiling, immune-cell activation, and translational inflammation studies. Its most useful application is a controlled comparison of receptor-driven responses, including IL-17A patterns relevant to maternal-neonatal infection research.
-
Biotin-HPDP Thiol Labeling Workflow
2026-09-29
Biotin-HPDP provides reversible biotinylation of accessible free thiols on proteins and other thiol-containing molecules, supporting streptavidin-based detection and affinity purification. It should be used with thiol-containing samples and appropriate cleanup controls; it is not a general amine-labeling reagent, and its water-insoluble nature requires careful preparation in DMSO or DMF.
-
ALC-0315: Practical LNP Workflow
2026-09-29
ALC-0315 is an ionizable amino lipid used to build lipid nanoparticles for nucleic acid drug delivery, including mRNA workflows. This guide covers solvent handling, mixing, QC, and failure analysis while defining the product as an LNP component rather than a water-soluble standalone delivery reagent or a substitute for formulation-specific evidence.
-
Chloroquine: From Lysosomal Biology to Translational Assays
2026-09-28
Chloroquine is more than an autophagy inhibitor: its lysosomal, immune, mitochondrial, and signaling effects shape how researchers interpret disease-model data. This evidence-led guide connects mechanism to assay selection across cancer, malaria, antiviral, and rheumatoid arthritis research.
-
Cholesterol (B1702) for Reliable Cell Assays
2026-09-28
A practical guide to using Cholesterol (SKU B1702) in cell viability, membrane-fluidity, and lipid nanoparticle workflows. It connects product specifications and handling decisions with assay controls, interpretation limits, and evidence from a 2026 p21 mRNA-LNP bladder cancer study.
-
β-NMN Workflows for Metabolic Regulation Research
2026-09-27
Use β-NMN to connect NAD+ metabolism with practical islet secretion and diabetic cardiac-remodeling experiments. This guide combines product handling, assay planning, and a recent SIRT3–GSK3β–Smad3 hypothesis while distinguishing reported findings from suggested workflows.
-
CGP 55845 Hydrochloride: Mapping GABAB Causality
2026-09-26
CGP 55845 hydrochloride is a potent GABAB receptor antagonist for testing how receptor signaling contributes to synaptic effects without confusing it with astrocytic GAT-3 activity. This article turns recent dentate-gyrus findings into a framework for interpreting antagonist experiments, choosing controls, and defining what the data can—and cannot—show.
-
ALC-0315: Practical LNP Handling and QC
2026-09-25
ALC-0315 is an ionizable amino lipid for researchers developing lipid nanoparticles for nucleic acid drug delivery, including mRNA workflows. This guide covers its handling and formulation-development use; it is not a water-soluble reagent or evidence that a particular LNP composition is validated for clinical use.
-
3-Deazaneplanocin (DZNep): Practical Research Workflows
2026-09-25
Use DZNep to connect SAHH inhibition and EZH2-associated chromatin changes with apoptosis, proliferation, and sphere-forming phenotypes. This guide outlines practical workflows for AML and hepatocellular carcinoma research, while emphasizing dose controls and the limits of extrapolating across tumor subtypes.
-
L. gasseri and E-Cadherin in DSS Colitis
2026-09-24
In a mouse model of DSS-induced colitis, Lactobacillus gasseri ATCC33323 improved inflammatory and intestinal-barrier outcomes, with E-cadherin emerging as an important part of its protective effect. The study links this response to NR1I3-associated regulation of CDH1, while its animal and in vitro design leaves clinical efficacy and the full causal pathway to be tested.
-
ALC-0315: Practical LNP Formulation Guide
2026-09-24
ALC-0315 is an ionizable amino lipid used as a component of lipid nanoparticles for research on mRNA and other nucleic acid delivery. It is intended for formulation with compatible lipids and nucleic acid—not as a water-soluble, standalone delivery reagent—and its product specifications do not establish a universal LNP recipe or biological performance.
-
Calpain Inhibitor I, ALLN: Practical Lab Guide
2026-09-23
Calpain Inhibitor I, ALLN (SKU A2602) is a water-insoluble cysteine-protease inhibitor for examining calpain- and cathepsin-associated proteolysis in apoptosis assays and ischemia-reperfusion injury models. Use it with vehicle-matched controls and empirically optimized conditions; it is not a calpain-only probe or a diagnostic or therapeutic product.
-
Cholesterol for Membrane and mRNA-LNP Research
2026-09-23
Cholesterol is a controllable formulation variable for membrane studies, lipid nanoparticle development, and localized mRNA delivery. This practical guide connects cholesterol handling, assay design, and troubleshooting with the intravesical p21 mRNA-LNP strategy reported for bladder cancer.
-
15-PGDH Inhibition Supports Muscle Repair During Weight Loss
2026-09-22
A 2026 PNAS study identifies 15-PGDH inhibition as a way to improve muscle regeneration and strength recovery during semaglutide-associated weight loss in obese mice. The combination enhanced muscle stem cell activity and regenerated myofiber growth without reducing semaglutide-driven weight loss, while also highlighting important limits for translation beyond the injury model.
-
RIG-I, c-Myc, and Renal Fibrosis in UUO Mice
2026-09-22
The reference study identifies RIG-I as an active driver of tubulointerstitial fibrosis rather than only an antiviral RNA sensor. Using UUO and folic acid injury models, the authors connect tubular epithelial inflammation to c-Myc-dependent fibroblast activation and TGF-β/Smad signaling, providing a mechanistic framework for studying inflammatory renal remodeling.